2005;**73**(2):671-678. DOI: 10.1128/ IAI.73.2.671-678.2005

[125] Russell AN, Zheng X, O'Connell CM, Taylor BD, Wiesenfeld HC, Hillier SL, et al. Analysis of factors driving incident and ascending infection and the role of serum antibody in chlamydia trachomatis genital tract infection. Journal of Infectious Diseases. 2016;**213**(4):523-531. DOI: 10.1093/ infdis/jiv438

[126] Linhares IM, Witkin SS. Immunopathogenic consequences of chlamydia trachomatis 60 kDa heat shock protein expression in the female reproductive tract. Cell Stress and Chaperones. 2010;**15**(5):467-473. DOI: 10.1007/s12192-010-0171-4

[127] von Hertzen LC. Role of persistent infection in the control and severity of asthma: Focus on chlamydia pneumoniae. European Respiratory Journal. 2002;**19**(3):546-556. DOI: 10.1183/09031936.02.00254402

[128] Dowell SF, Peeling RW, Boman J, Carlone GM, Fields BS, Guarner J, et al. Standardizing chlamydia pneumoniae assays: Recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clinical Infectious Diseases. 2001;**33**(4): 492-503. DOI: 10.1086/322632
